Tag: BRAF
Broad Molecular Testing in Lung Cancer: The Struggle to Translate Recommendations...
By Kara Nyberg, PhD
Posted: June 24, 2020
Over the past decade, lung cancer has emerged as a shining example of how precision medicine can dramatically...
Lung Cancer Leading the Charge for Tumor-Agnostic Targeted Therapies
By Robert C. Doebele, MD, PhD
Posted: December 11, 2019
Early in the drug development of targeted therapies, specific oncogene mutations were often associated with a...
